Hitchhiking on host chromatin: How papillomaviruses persist

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1819, Issue 7, 2012, Pages 820-825

  McBride, Alison A ^a   Sakakibara, Nozomi ^a   Stepp, Wesley H ^a   Jang, Moon Kyoo ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Chromatin; DNA damage response; HPV; ND10; Replication; Virus

Indexed keywords

CAPSID PROTEIN L1; DAXX PROTEIN; GLYCOPROTEIN E1; GLYCOPROTEIN E2; VIRUS DNA;

BINDING SITE; CELL DIFFERENTIATION; CHROMATIN; CHROMOSOME; COPY NUMBER VARIATION; CYTOPLASM; DESMOSOME; DNA DAMAGE; DNA METHYLATION; DNA REPLICATION; DNA SYNTHESIS; ENDOCYTOSIS; GENE AMPLIFICATION; GENE EXPRESSION; GENOMIC INSTABILITY; HETEROCHROMATIN; HISTONE MODIFICATION; HOST RESISTANCE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; LIFE CYCLE; MITOSIS; NUCLEUS ACCUMBENS; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REVIEW; SELECTIVE SWEEP; STRATUM CORNEUM; VIRUS RELEASE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ALPHAPAPILLOMAVIRUS; ANIMALS; CHROMATIN; CHROMOSOME SEGREGATION; CHROMOSOMES, HUMAN; DNA-BINDING PROTEINS; GENOME, VIRAL; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 84861862321     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2012.01.011     Document Type: Review

References (44)

1. Bastien N., McBride A.A. Interaction of the papillomavirus E2 protein with mitotic chromosomes. Virology 2000, 270:124.
2. Baxter M.K., McPhillips M.G., Ozato K., McBride A.A. The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4. J. Virol. 2005, 79:4806.
3. Bodily J., Laimins L.A. Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol. 2011, 19:33.
4. Cardenas-Mora J., Spindler J.E., Jang M.K., McBride A.A. Dimerization of the papillomavirus E2 protein is required for efficient mitotic chromosome association and Brd4 binding. J. Virol. 2008, 82:7298.
5. Chen H.C., Schiffman M., Lin C.Y., Pan M.H., You S.L., Chuang L.C., Hsieh C.Y., Liaw K.L., Hsing A.W., Chen C.J. Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J. Natl. Cancer Inst. 2011, 103:1387.
6. Day P.M., Baker C.C., Lowy D.R., Schiller J.T. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:14252.
7. Day P.M., Roden R.B., Lowy D.R., Schiller J.T. The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J. Virol. 1998, 72:142.
8. Dey A., Chitsaz F., Abbasi A., Misteli T., Ozato K. The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8758.
9. Donaldson M.M., Boner W., Morgan I.M. TopBP1 regulates human papillomavirus type 16 E2 interaction with chromatin. J. Virol. 2007, 81:4338.
10. Everett R.D., Chelbi-Alix M.K. PML and PML nuclear bodies: implications in antiviral defence. Biochimie 2007, 89:819.
11. Favre M., Breitburd F., Croissant O., Orth G. Chromatin-like structures obtained after alkaline disruption of bovine and human papillomaviruses. J. Virol. 1977, 21:1205.
12. Florin L., Schafer F., Sotlar K., Streeck R.E., Sapp M. Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2. Virology 2002, 295:97.
13. Fradet-Turcotte A., Bergeron-Labrecque F., Moody C.A., Lehoux M., Laimins L.A., Archambault J. Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J. Virol. 2011, 85:8996.
14. Gillison M.L., Lowy D.R. A causal role for human papillomavirus in head and neck cancer. Lancet 2004, 363:1488.
15. Hasan U.A., Bates E., Takeshita F., Biliato A., Accardi R., Bouvard V., Mansour M., Vincent I., Gissmann L., Iftner T., Sideri M., Stubenrauch F., Tommasino M. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. J. Immunol. 2007, 178:3186.
16. Ilves I., Kivi S., Ustav M. Long-term episomal maintenance of bovine papillomavirus type 1 plasmids is determined by attachment to host chromosomes, which is mediated by the viral E2 protein and its binding sites. J. Virol. 1999, 73:4404.
17. Ilves I., Maemets K., Silla T., Janikson K., Ustav M. Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle. J. Virol. 2006, 80:3660.
18. Jang M.K., Kwon D., McBride A.A. Papillomavirus E2 proteins and the host BRD4 protein associate with transcriptionally active cellular chromatin. J. Virol. 2009, 83:2592.
19. Kamper N., Day P.M., Nowak T., Selinka H.C., Florin L., Bolscher J., Hilbig L., Schiller J.T., Sapp M. A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J. Virol. 2006, 80:759.
20. Kurg R., Sild K., Ilves A., Sepp M., Ustav M. Association of bovine papillomavirus E2 protein with nuclear structures in vivo. J. Virol. 2005, 79:10528.
21. Lang M., Jegou T., Chung I., Richter K., Munch S., Udvarhelyi A., Cremer C., Hemmerich P., Engelhardt J., Hell S.W., Rippe K. Three-dimensional organization of promyelocytic leukemia nuclear bodies. J. Cell Sci. 2010, 123:392.
22. McBride A.A. Replication and partitioning of papillomavirus genomes. Adv. Virus Res. 2008, 72:155.
23. McPhillips M.G., Oliveira J.G., Spindler J.E., Mitra R., McBride A.A. Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J. Virol. 2006, 80:9530.
24. McPhillips M.G., Ozato K., McBride A.A. Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin. J. Virol. 2005, 79:8920.
25. Moody C.A., Laimins L.A. Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS. Pathog. 2009, 5:e1000605.
26. Oliveira J.G., Colf L.A., McBride A.A. Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:1047.
27. Parish J.L., Bean A.M., Park R.B., Androphy E.J. ChlR1 is required for loading papillomavirus E2 onto mitotic chromosomes and viral genome maintenance. Mol. Cell 2006, 24:867.
28. Piirsoo M., Ustav E., Mandel T., Stenlund A., Ustav M. Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator. EMBO J. 1996, 15:1.
29. Poddar A., Reed S.C., McPhillips M.G., Spindler J.E., McBride A.A. The human papillomavirus type 8 E2 tethering protein targets the ribosomal DNA loci of host mitotic chromosomes. J. Virol. 2009, 83:640.
30. Pyeon D., Pearce S.M., Lank S.M., Ahlquist P., Lambert P.F. Establishment of human papillomavirus infection requires cell cycle progression. PLoS. Pathog. 2009, 5:e1000318.
31. Sakakibara N., Mitra R., McBride A.A. The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci. J. Virol. 2011, 85:8981.
32. Schelhaas M. Come in and take your coat off-how host cells provide endocytosis for virus entry. Cell. Microbiol. 2010, 12:1378.
33. Schiller J.T., Day P.M., Kines R.C. Current understanding of the mechanism of HPV infection. Gynecol. Oncol. 2010, 118:S12-S17.
34. Schweiger M.R., You J., Howley P.M. Bromodomain protein 4 mediates the papillomavirus e2 transcriptional activation function. J. Virol. 2006, 80:4276.
35. Sekhar V., Reed S.C., McBride A.A. Interaction of the Betapapillomavirus E2 Tethering Protein With Mitotic Chromosomes, J. Virol. 2010, 84:543-557.
36. Senechal H., Poirier G.G., Coulombe B., Laimins L.A., Archambault J. Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4. Virology 2007, 358:10.
37. Skiadopoulos M.H., McBride A.A. Bovine papillomavirus type 1 genomes and the E2 transactivator protein are closely associated with mitotic chromatin. J. Virol. 1998, 72:2079.
38. Smith J.A., White E.A., Sowa M.E., Powell M.L., Ottinger M., Harper J.W., Howley P.M. Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3752.
39. Tavalai N., Stamminger T. New insights into the role of the subnuclear structure ND10 for viral infection. Biochim. Biophys. Acta 2008, 1783:2207.
40. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., oz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189:12.
41. Wang H.K., Duffy A.A., Broker T.R., Chow L.T. Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev. 2009, 23:181.
42. Wu S.Y., Chiang C.M. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J. Biol. Chem. 2007, 282:13141.
43. You J., Croyle J.L., Nishimura A., Ozato K., Howley P.M. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 2004, 117:349.
44. You J.X., Schweiger M.R., Howley P.M. Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells. J. Virol. 2005, 79:14956.